It's is being sold whether it sells or not it's a different story. Some priceline stores may have removed the stock to clear up shelve space. There is no point having dead stock on shelves if it doesn't sell.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025